A study of the effect and safety of transcutaneous application of carbon dioxide on post-polio syndrome.

A study of the effect and safety of transcutaneous application of carbon dioxide on post-polio syndrome. - The effect of transcutaneous application of CO2 on post-plio syndrome.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013842

Enrollment

Registered

2014-06-01

Start date

2014-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Polio Syndrome

Interventions

Transcutaneous application of CO2

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. patients with muscle weakness in post polio syndrome 2. patients who are 20 years old or older 3. patients who can obtain informed consent with written by themselves or regal representive.

Exclusion criteria

Exclusion criteria: 1.Patients with arteriosclerosis obliterans (Fontaine III-IV) 2.Patients with chronic heart failure (NYHA IV) 3.Possibility of pregnancy 4.Respiratory failure (%VC60% or less) 5. Severe anemia (Hb 7.0 g/dl or less 6.Large skin ulcer or severe skin disorder 7.Researcher's decision of unsuitable

Design outcomes

Primary

Measure	Time frame
Electromyogram Visual analog scales for coldness, pain, fatigue and general conditions. Muscle power	—

Countries

Japan

Contacts

Public ContactYoshitada Sakai

Kobe University Graduate School of Medicine Division of Rehabilitation Medicine

yossie@med.kobe-u.ac.jp078-382-6826

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026